Food and Drug Administration report describes concerning conditions at Baltimore site where manufacturing was halted
A US Food and Drug Administration inspection report found unsanitary conditions and other problems at a Baltimore manufacturing plant that ruined more than 15m doses of Johnson & Johnson coronavirus vaccine.
The FDA reported the plant operated by Emergent BioSolutions “is not maintained in a clean and sanitary condition”. The report says the paint on the plant’s walls were peeling in several areas and paint flecks were found on the floor.
Read the original article at The Guardian